Combining a first-in-class SLAMF7 antibody with SIRPĪ± blockade for anti-tumor immunity
Crossref DOI link: https://doi.org/10.1038/s41590-023-01673-0
Published Online: 2023-11-13
Published Print: 2023-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Text and Data Mining valid from 2023-11-13
Version of Record valid from 2023-11-13
Article History
First Online: 13 November 2023